Paper24676319
Current evidence for the use of coffee and caffeine to prevent age-related cognitive decline and Alzheimer's disease.
Carman AJ and 4 others. J Nutr Health Aging, 2014. Cited by 43 papers, by iCite.
Cite this record
ConductScience Library. Current evidence for the use of coffee and caffeine to prevent age-related cognitive decline and Alzheimer's disease. Papers, record 24676319. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24676319
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Current evidence for the use of coffee and caffeine to prevent age-related cognitive decline and Alzheimer's disease.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aging | Major topic |
| Alzheimer Disease | Major topic |
| Caffeine | Major topic |
| Coffee | Major topic |
| Cognition Disorders | Major topic |
| Neuroprotective Agents | Major topic |
| Animals | |
| Cognition | |
| Humans | |
| Memory, Short-Term | |
| Precision Medicine |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT05170113 | Evaluate the Effectiveness and Safety of the Alpinia Galanga Formulation, Theacrine Formulation, and Caffeine Formulation on Fatigue, Mental Acuity, and Cognitive Health | Background |
Source ClinicalTrials.gov
References138
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12550056 | Chlorogenic acid modifies plasma and liver concentrations of: cholesterol, triacylglycerol, and minerals in (fa/fa) Zucker rats. | J Nutr Biochem | 2002 | https://conductscience.org/library/papers/12550056 | PubMed |
| 2 | 20182052 | Caffeine, cognition, and socioeconomic status. | J Alzheimers Dis | 2010 | https://conductscience.org/library/papers/20182052 | PubMed |
| 3 | 21357676 | Sequence variants at CYP1A1-CYP1A2 and AHR associate with coffee consumption. | Hum Mol Genet | 2011 | https://conductscience.org/library/papers/21357676 | PubMed |
| 4 | 20182026 | Caffeine intake and dementia: systematic review and meta-analysis. | J Alzheimers Dis | 2010 | https://conductscience.org/library/papers/20182026 | PubMed |
| 5 | 20164566 | Caffeine and adenosine. | J Alzheimers Dis | 2010 | https://conductscience.org/library/papers/20164566 | PubMed |
| 6 | 23479184 | Sleep quality and preclinical Alzheimer disease. | JAMA Neurol | 2013 | https://conductscience.org/library/papers/23479184 | PubMed |
| 7 | 23238034 | Effects of coffee consumption in chronic hepatitis C: a randomized controlled trial. | Dig Liver Dis | 2013 | https://conductscience.org/library/papers/23238034 | PubMed |
| 8 | 23110387 | The association between cognitive function and white matter lesion location in older adults: a systematic review. | BMC Neurol | 2012 | https://conductscience.org/library/papers/23110387 | PubMed |
| 9 | 23390181 | Alzheimer disease in the United States (2010-2050) estimated using the 2010 census. | Neurology | 2013 | https://conductscience.org/library/papers/23390181 | PubMed |
| 10 | 17284734 | Caffeinated beverage intake and the risk of heart disease mortality in the elderly: a prospective analysis. | Am J Clin Nutr | 2007 | https://conductscience.org/library/papers/17284734 | PubMed |
| 11 | 22072103 | Antihypertensive effects and mechanisms of chlorogenic acids. | Hypertens Res | 2012 | https://conductscience.org/library/papers/22072103 | PubMed |
| 12 | 21693129 | Chronic coffee and caffeine ingestion effects on the cognitive function and antioxidant system of rat brains. | Pharmacol Biochem Behav | 2011 | https://conductscience.org/library/papers/21693129 | PubMed |
| 13 | 19581723 | Caffeine suppresses amyloid-beta levels in plasma and brain of Alzheimer's disease transgenic mice. | J Alzheimers Dis | 2009 | https://conductscience.org/library/papers/19581723 | PubMed |
| 14 | 23393697 | Neurocognitive dysfunction in old diabetes: management and treatment. | Adv Exp Med Biol | 2012 | https://conductscience.org/library/papers/23393697 | PubMed |
| 15 | 12397002 | Coffee consumption and cognitive function among older adults. | Am J Epidemiol | 2002 | https://conductscience.org/library/papers/12397002 | PubMed |
| 16 | 22801742 | Blood-based protein biomarkers for diagnosis of Alzheimer disease. | Arch Neurol | 2012 | https://conductscience.org/library/papers/22801742 | PubMed |
| 17 | 10049999 | Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. | Pharmacol Rev | 1999 | https://conductscience.org/library/papers/10049999 | PubMed |
| 18 | 19940169 | Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by beta-amyloid peptides via p38 mitogen-activated protein kinase pathway. | J Neurosci | 2009 | https://conductscience.org/library/papers/19940169 | PubMed |
| 19 | 17679672 | The neuroprotective effects of caffeine: a prospective population study (the Three City Study). | Neurology | 2007 | https://conductscience.org/library/papers/17679672 | PubMed |
| 20 | 12067578 | Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity. | Food Chem Toxicol | 2002 | https://conductscience.org/library/papers/12067578 | PubMed |
Cited by29
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 43 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42807111 | Bioregulatory periodontal medicine: could the molecular networks, inflammation and system biology modify the auto-regulatory capacity of the patients? | Front Physiol | 2026 | https://conductscience.org/library/papers/42807111 | PubMed |
| 42040972 | Efficient aqueous solubilization of methylxanthines via complexation with natural polyphenolate salts. | RSC Adv | 2026 | https://conductscience.org/library/papers/42040972 | PubMed |
| 41999921 | Caffeine extends lifespan by enhancing lysosomal lipolysis in Caenorhabditis elegans. | Mol Cells | 2026 | https://conductscience.org/library/papers/41999921 | PubMed |
| 41097555 | Novel Insights into Torrefacto and Natural Coffee Silverskin: Composition, Bioactivity, Safety, and Environmental Impact for Sustainable Food Applications. | Foods | 2025 | https://conductscience.org/library/papers/41097555 | PubMed |
| 40869757 | Caffeine in Aging Brains: Cognitive Enhancement, Neurodegeneration, and Emerging Concerns About Addiction. | Int J Environ Res Public Health | 2025 | https://conductscience.org/library/papers/40869757 | PubMed |
| 40650030 | Caffeine as a Modulator in Oncology: Mechanisms of Action and Potential for Adjuvant Therapy. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40650030 | PubMed |
| 40334227 | Joint association between physical exercise, caffeine intake, and biological ageing: A cross-sectional analysis of population-based study. | PLoS One | 2025 | https://conductscience.org/library/papers/40334227 | PubMed |
| 40255824 | Association Between Caffeine Intake and Alzheimer's Disease Progression: A Systematic Review. | Cureus | 2025 | https://conductscience.org/library/papers/40255824 | PubMed |
| 39673298 | Coffee Consumption Correlates With Better Cognitive Performance in Patients With a High Incidence for Stroke. | J Am Heart Assoc | 2025 | https://conductscience.org/library/papers/39673298 | PubMed |
| 37603263 | Over the Counter Supplements for Memory: A Review of Available Evidence. | CNS Drugs | 2023 | https://conductscience.org/library/papers/37603263 | PubMed |
| 37466260 | Espresso Coffee Mitigates the Aggregation and Condensation of Alzheimer's Associated Tau Protein. | J Agric Food Chem | 2023 | https://conductscience.org/library/papers/37466260 | PubMed |
| 37396132 | Potential neuroprotective effects of fermented foods and beverages in old age: a systematic review. | Front Nutr | 2023 | https://conductscience.org/library/papers/37396132 | PubMed |
| 35615593 | Relationships Between Traditional Chinese Medicine Constitution and Age-Related Cognitive Decline in Chinese Centenarians. | Front Aging Neurosci | 2022 | https://conductscience.org/library/papers/35615593 | PubMed |
| 35069225 | Caffeine Protects Against Retinal Inflammation. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/35069225 | PubMed |
| 33050475 | Diet, Microbiota and Brain Health: Unraveling the Network Intersecting Metabolism and Neurodegeneration. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/33050475 | PubMed |
| 32438643 | Metabolites, Nutrients, and Lifestyle Factors in Relation to Coffee Consumption: An Environment-Wide Association Study. | Nutrients | 2020 | https://conductscience.org/library/papers/32438643 | PubMed |
| 32078115 | Caffeine exposure ameliorates acute ischemic cell death in avian developing retina. | Purinergic Signal | 2020 | https://conductscience.org/library/papers/32078115 | PubMed |
| 29982422 | Age Modulates the Association of Caffeine Intake With Cognition and With Gray Matter in Elderly Diabetics. | J Gerontol A Biol Sci Med Sci | 2019 | https://conductscience.org/library/papers/29982422 | PubMed |
| 29405240 | Letter to the editor: Responses. Long-Term Tea Consumption and Depressive and Anxiety Symptoms in Elderly. | J Prev Alzheimers Dis | 2018 | https://conductscience.org/library/papers/29405240 | PubMed |
| 28507563 | Can coffee consumption lower the risk of Alzheimer's disease and Parkinson's disease? A literature review. | Arch Med Sci | 2017 | https://conductscience.org/library/papers/28507563 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24676319
GET https://conductscience.org/api/papers/v1/24676319/references?page=2